رجوع
46
62
نطاق اليوم
KWD 348.61
KWD 353.42
نطاق 52 أسبوعًا
KWD 261.43
KWD 391.29
حجم التداول
2,218,975
متوسط 50 يوم / 200 يوم
KWD 359.42
/
KWD 316.58
الإغلاق السابق
KWD 347.80
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 24.5 | 0.4 |
| P/B | 21.8 | 2.9 |
| ROE % | 106.1 | 3.7 |
| Net Margin % | 21.0 | 3.9 |
| Rev Growth 5Y % | 9.1 | 10.0 |
| D/E | 6.3 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 347.730
-0.6%
Low: KWD 185.000
High: KWD 432.000
مكرر الربحية المستقبلي
15.6
ربحية السهم المستقبلية
KWD 22.408
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
38 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 27.531
KWD 26.563 – KWD 29.061
|
43 B | 4 |
| FY2029 |
KWD 25.481
KWD 24.585 – KWD 26.897
|
41 B | 4 |
| FY2028 |
KWD 24.221
KWD 18.949 – KWD 32.360
|
40 B | 10 |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 |
Santos Esteban
EVP, Operations
|
other | 5,621 | KWD 366.210 | KWD 2,058,466 |
| Mar 16, 2026 |
Gordon Murdo
EVP, Global Commercial Ops
|
other | 6,691 | KWD 366.210 | KWD 2,450,311 |
| Mar 16, 2026 |
Graham Jonathan P
EVP & Gen. Counsel & Sec.
|
other | 5,353 | KWD 366.210 | KWD 1,960,322 |
| Mar 16, 2026 |
Miller Derek
SVP, Human Resources
|
other | 1,616 | KWD 366.210 | KWD 591,795 |
| Mar 3, 2026 |
REESE DAVID M
EVP & Chief Technology Officer
|
grant | 12,063 | — | — |
| Mar 3, 2026 |
Grygiel Nancy A.
SVP & CCO
|
grant | 2,010 | — | — |
| Mar 3, 2026 |
Miller Derek
SVP, Human Resources
|
grant | 3,484 | — | — |
| Mar 3, 2026 |
Khosla Rachna
SVP, Business Development
|
grant | 1,876 | — | — |
| Feb 19, 2026 |
Busch Matthew C.
VP, Finance & CAO
|
sell | 1,000 | KWD 375.790 | KWD 375,790 |
| Nov 12, 2025 |
Khosla Rachna
SVP, Business Development
|
sell | 890 | KWD 336.242 | KWD 299,256 |
| Aug 8, 2025 |
HOLLEY CHARLES M
Director
|
grant | 147 | — | — |
| Aug 8, 2025 |
ISHRAK OMAR
Director
|
grant | 121 | — | — |
| May 23, 2025 |
Jacks Tyler
Director
|
grant | 809 | — | — |
| May 23, 2025 |
ECKERT ROBERT
Director
|
grant | 809 | — | — |
| May 23, 2025 |
Garland Greg C.
Director
|
grant | 809 | — | — |
| May 23, 2025 |
Austin Wanda M
Director
|
grant | 809 | — | — |
| May 6, 2025 |
ISHRAK OMAR
Director
|
grant | 129 | — | — |
| May 6, 2025 |
Busch Matthew C.
VP, Finance & CAO
|
grant | 4,139 | — | — |
| May 2, 2025 |
Bradway Robert A
Chairman, CEO and President
|
other | 4,833 | KWD 283.780 | KWD 1,371,509 |
| May 2, 2025 |
Griffith Peter H.
EVP & CFO
|
other | 1,367 | KWD 283.780 | KWD 387,927 |
النقاط الرئيسية
Revenue grew 9.05% annually over 5 years — modest growth
Earnings grew 88.53% over the past year
ROE of 106.10% indicates high profitability
Net margin of 20.99% shows strong profitability
Debt/Equity of 6.31 — high leverage
Generating 8.10B in free cash flow
النمو
Revenue Growth (5Y)
9.05%
Revenue (1Y)9.92%
Earnings (1Y)88.53%
FCF Growth (3Y)4.91%
الجودة
Return on Equity
106.10%
ROIC12.66%
Net Margin20.99%
Op. Margin29.06%
الأمان
Debt / Equity
6.31
Current Ratio1.14
Interest Coverage3.88
التقييم
P/E Ratio
24.45
P/B Ratio21.78
EV/EBITDA21.92
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9.92% | Revenue Growth (3Y) | 14.16% |
| Earnings Growth (1Y) | 88.53% | Earnings Growth (3Y) | 7.14% |
| Revenue Growth (5Y) | 9.05% | Earnings Growth (5Y) | 6.95% |
| Profitability | |||
| Revenue (TTM) | 36.74B | Net Income (TTM) | 7.71B |
| ROE | 106.10% | ROA | 8.51% |
| Gross Margin | 70.80% | Operating Margin | 29.06% |
| Net Margin | 20.99% | Free Cash Flow (TTM) | 8.10B |
| ROIC | 12.66% | FCF Growth (3Y) | 4.91% |
| Safety | |||
| Debt / Equity | 6.31 | Current Ratio | 1.14 |
| Interest Coverage | 3.88 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 24.45 | P/B Ratio | 21.78 |
| P/S Ratio | 5.13 | PEG Ratio | 0.26 |
| EV/EBITDA | 21.92 | Dividend Yield | 0.03% |
| Market Cap | 188.55B | Enterprise Value | 234.02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 36.74B | 33.42B | 28.19B | 26.32B | 25.98B |
| Net Income | 7.71B | 4.09B | 6.72B | 6.55B | 5.89B |
| EPS (Diluted) | 14.23 | 7.56 | 12.49 | 12.11 | 10.28 |
| Gross Profit | 26.01B | 20.57B | 19.78B | 19.92B | 19.53B |
| Operating Income | 10.68B | 7.26B | 7.90B | 9.57B | 7.64B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 90.59B | 91.84B | 97.15B | 65.12B | 61.17B |
| Total Liabilities | 81.93B | 85.96B | 90.92B | 61.46B | 54.47B |
| Shareholders' Equity | 8.66B | 5.88B | 6.23B | 3.66B | 6.70B |
| Total Debt | 54.60B | 60.10B | 64.61B | 38.95B | 33.31B |
| Cash & Equivalents | 9.13B | 11.97B | 10.94B | 7.63B | 7.99B |
| Current Assets | 29.06B | 29.03B | 30.33B | 22.19B | 19.39B |
| Current Liabilities | 25.49B | 23.10B | 18.39B | 15.69B | 12.18B |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Light Compounder
#84 of 213
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#87 of 326
النشاط الأخير
دخل
Capital Light Compounder
Mar 24, 2026
دخل
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026